Ovarian Cancer Canada

Western Regional Blog – BC, YK, AB, NWT and Nunavut

CDC’s Cervical Cancer Study (US Centers for Disease Control)

Source: National Cancer Institute http://www.cdc.gov/cancer/dcpc/research/articles/cervical-cancer-study.htm  Cervical cancer is most often caused by a genital human papillomavirus (HPV) infection. HPV infection is common and often goes away on its own. Persistent … Continue reading

April 1, 2014

Bevacizumab Improves Survival in Cervical Cancer

Abstract: N Engl J Med. 2014;370(8):734-743.  Results of the Gynecologic Oncology Group (GOG) Trial 240 showed that the addition of bevacizumab to combination chemotherapy in patients with recurrent, persistent, or … Continue reading

April 1, 2014

For Women’s Cancers, Where You’re Treated Matters

Patients at highest-volume hospitals live more than a year longer on average, study finds  By Robert Preidt http://www.nlm.nih.gov/medlineplus/news/fullstory_145272.html  MONDAY, March 24, 2014 (HealthDay News) — Where you’re treated for ovarian … Continue reading

April 1, 2014

FDA Panel Recommends HPV Test As Replacement for Pap Smear

Experts voted 13-0 that Roche’s test was safe and effective as first step in cervical cancer screening.  http://www.nlm.nih.gov/medlineplus/news/fullstory_145075.html  WEDNESDAY, March 12, 2014 (HealthDay News) — A U.S. Food and Drug … Continue reading

April 1, 2014

Measuring the Nature and Duration of Symptoms of Cervical Cancer in Young Women

“Interview-based measure (Cervical Cancer History of Presentation Schedule) for use in a nationwide study of delayed diagnosis of cervical cancer in young women. This will be crucial to enable us … Continue reading

March 17, 2014

Pap Smears in Perpetuity

By PAULA SPAN  Most older women don’t need the routine Pap tests used to check for cervical cancer. There are exceptions, which I’ll get to in a minute. But since … Continue reading

March 3, 2014

Cancer Regression with Therapeutic HPV Vaccine

“These findings indicate that peripheral therapeutic vaccination to HPV antigens can induce a robust tissue-localized effector immune response, and that analyses of immune responses at sites of antigen are likely to be … Continue reading

February 1, 2014

2013 Ob/Gyn & Women’s Health Game Changers

Oral Contraceptive Pills as Primary Prevention for Ovarian Cancer: A Systematic Review and Meta-analysis Peter Kovacs, MD, PhD Havrilesky LJ, Moorman PG, Lowery WJ, et al Obstet Gynecol. 2013;122:139-147 http://www.medscape.com/viewarticle/818156_2 Summary … Continue reading

January 16, 2014

Many Women with Cancer Not Told About Impaired Fertility Risk

“Only 60% of women with uterine cancers and 42% of women with ovarian cancers were told about the effects of treatment on fertility, despite having cancers of the reproductive system.” IMNG … Continue reading

December 12, 2013

Complementary and Alternative Therapies

CAMEO

Research in BC

The Injustices of Ovarian Cancer

Ovarian Cancer Canada